| The prognostic role of circulating tumor cells (CTCs) in lung cancer J Kapeleris, A Kulasinghe, ME Warkiani, I Vela, L Kenny, K O'Byrne, ... Frontiers in oncology 8, 311, 2018 | 110 | 2018 |
| The prognostic significance of circulating tumor cells in head and neck and non‐small‐cell lung cancer A Kulasinghe, J Kapeleris, R Kimberley, SR Mattarollo, EW Thompson, ... Cancer Medicine 7 (12), 5910-5919, 2018 | 106 | 2018 |
| Phenotypic characterization of circulating lung cancer cells for clinically actionable targets A Kulasinghe, J Kapeleris, C Cooper, ME Warkiani, K O’Byrne, ... Cancers 11 (3), 380, 2019 | 35 | 2019 |
| Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer J Kapeleris, A Kulasinghe, ME Warkiani, C Oleary, I Vela, P Leo, ... Translational lung cancer research 9 (5), 1795, 2020 | 28 | 2020 |
| Cancer stemness contributes to cluster formation of colon cancer cells and high metastatic potentials J Kapeleris, H Zou, Y Qi, Y Gu, J Li, J Schoning, MJ Monteiro, W Gu Clinical and Experimental Pharmacology and Physiology 47 (5), 838-847, 2020 | 28 | 2020 |
| Clinical applications of circulating tumour cells and circulating tumour DNA in non-small cell lung cancer—an update J Kapeleris, M Ebrahimi Warkiani, A Kulasinghe, I Vela, L Kenny, ... Frontiers in oncology 12, 859152, 2022 | 17 | 2022 |
| The use of three-dimensional dna fluorescent in situ hybridization (3D DNA FISH) for the detection of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC … A Kulasinghe, Y Lim, J Kapeleris, M Warkiani, K O’Byrne, C Punyadeera Cells 9 (6), 1465, 2020 | 15 | 2020 |
| Inhibition of colon cancer K-RasG13D mutation reduces cancer cell proliferation but promotes stemness and inflammation via RAS/ERK pathway Y Qi, H Zou, XH Zhao, J Kapeleris, M Monteiro, F Li, ZP Xu, Y Deng, Y Wu, ... Frontiers in Pharmacology 13, 996053, 2022 | 5 | 2022 |
| Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer J Kapeleris, JM Bark, S Ranjit, D Irwin, G Hartel, ME Warkiani, P Leo, ... Heliyon 8 (7), 2022 | 4 | 2022 |
| Modelling reoxygenation effects in non-small cell lung cancer cell lines and showing epithelial-mesenchymal transition J Kapeleris, J Müller Bark, S Ranjit, D Richard, I Vela, K O’Byrne, ... Journal of Cancer Research and Clinical Oncology 148 (12), 3501-3510, 2022 | 3 | 2022 |
| Characterization of the tumor microenvironment and liquid biopsy in head and neck and non-small cell lung cancer A Kulasinghe, J Kapeleris, L Kenny, B Hughes, M Warkiani, I Vela, ... Cancer Research 80 (16_Supplement), 3384-3384, 2020 | 1 | 2020 |
| Isolation, characterization and expansion of circulating tumor cells in solid cancers A Kulasinghe, J Kapeleris, L Kenny, M Warkiani, I Vela, JP Thiery, ... Cancer Research 79 (13_Supplement), 1333-1333, 2019 | 1 | 2019 |
| Circulating tumour cells in non-small cell lung cancer JC Kapeleris Queensland University of Technology, 2022 | | 2022 |
| Abstract A03: Isolation, characterization, and expansion of circulating tumor cells in head and neck cancers A Kulasinghe, J Kapeleris, L Kenny, M Warkiani, I Vela, JP Thiery, ... Clinical Cancer Research 26 (12_Supplement_2), A03-A03, 2020 | | 2020 |
| Culture of circulating tumour cells derived from non-small cell lung cancer. KJ O'byrne, J Kapeleris, A Kulasinghe, ME Warkiani, CG O'leary, R Ladwa, ... Journal of Clinical Oncology 38 (15_suppl), e21692-e21692, 2020 | | 2020 |
